<DOC>
	<DOCNO>NCT02301416</DOCNO>
	<brief_summary>This study test efficacy medication , Qsymia , adjunct therapy superobese individual plan undergo weight loss surgery . Individuals take medication surgery compare historical control surgery without take medication .</brief_summary>
	<brief_title>Qsymia Adjunct Surgical Therapy Superobese</brief_title>
	<detailed_description>While obvious focus obesity epidemic affect approximately one-third U.S. population , one subgroup within epidemic remains fringe scientific study effective treatment option . The super obese patient , instance define BMI ≥ 50 kg/m2 , present difficult treatment challenge manage level obesity . While bariatric surgery , include Roux-en-Y gastric bypass biliopancreatic diversion duodenal switch , show effective severe obesity ( BMI ≥ 40 kg/m2 ) , risk involve surgical intervention super obese patient high . Qsymia provide potential opportunity develop effective treatment plan would adjunct surgical intervention super obese patient . Use Qsymia addition low-calorie dietary prescription pre-operatively would effectively decrease weight prior surgical intervention , lower surgical risk extent . Additionally , continue post-operatively , Qsymia adjunct post-surgical dietary plan would potentially extend weight loss horizon probability typical weight loss plateau 12-18 month decrease .</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Phentermine</mesh_term>
	<criteria>BMI ≥ 50 kg/m2 Determined good candidate surgery base medical psychological exam . Willing participate 36 month medically supervise weight loss plan prior surgery . Planning remain reasonable vicinity Wake Forest Baptist Health Weight Management Center duration study . History prior weight loss surgery ( removal/conversion band sleeve exclude ) Pregnant ( woman childbearing potential complete pregnancy test ( blood draw ) make sure pregnant time initiate medication ) . Ongoing monitoring pregnancy status responsibility patient instruct consent form . Ongoing use weight loss medication Contraindications use Qsymia , include pregnancy , history glaucoma , unstable cardiac disease ( unstable angina , recent heart attack stroke ( past 6 month ) , uncontrolled arrhythmia ) , hyperthyroidism , take MAOIs ( monoamine oxidase inhibitor ) allergy either topiramate sympathomimetic amine like phentermine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>